Dice Therapeutics
(NASDAQ) DICE
This security has been delisted. This page is retained for historical reference.
DICE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowDICE Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
56%
Return on Capital
-15%
Return on Assets
-14%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$88.22M
EBITDA
$83.01M
Operating Cash Flow
$64.32M
Capital Expenditure
$2.24M
Free Cash Flow
$66.56M
Cash & ST Invst.
$574.23M
Total Debt
$13.27M
Dice Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
71
N/A
Net Income
$34.82M
-60.3%
EBITDA
$34.13M
-66.0%
Quarterly Fundamentals
Net Cash
$515.80M
+92.2%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$11.05M
-12.2%
Short Term Debt
$1.53M
+16.2%
Return on Assets
-13.75%
N/A
Return on Invested Capital
-15.24%
N/A
Free Cash Flow
$30.41M
-70.5%
Operating Cash Flow
$28.58M
-68.7%